ARTTX
Price
$22.37
Change
-$0.69 (-2.99%)
Updated
Feb 21 closing price
Net Assets
1.08B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

ARTTX vs GFACX

Header iconARTTX vs GFACX Comparison
Open Charts ARTTX vs GFACXBanner chart's image
Artisan Focus Fund Investor
Price$22.37
Change-$0.69 (-2.99%)
VolumeN/A
Net Assets1.08B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
ARTTX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARTTX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTTX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. ARTTX (1.08B). ARTTX (0.00) and GFACX (0.00) have matching dividends . ARTTX was incepted earlier than GFACX: ARTTX (8 years) vs GFACX (24 years). ARTTX is a more actively managed with annual turnover of: 271.28 vs. GFACX (31.00). GFACX has a lower initial minimum investment than ARTTX: GFACX (250) vs ARTTX (1000). ARTTX annual gain was more profitable for investors over the last year : 11.24 vs. GFACX (10.15). GFACX (32.83) and ARTTX (31.98) have equivalent 5 years return.
ARTTXGFACXARTTX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD4.1432.980139%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.08B304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.2410.15111%
Returns for 3 years23.6617.69134%
Returns for 5 years31.9832.8397%
Returns for 10 yearsN/A55.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding